News - Sigma Tau


Current filters:

Sigma Tau

Popular Filters

EMA recommendations to deal with sterility concerns for DepoCyte


The European Medicines Agency last Friday agreed a number of precautionary measures to deal with manufacturing…

DepoCyteEuropeMundipharmaOncologyPacira PharmaceuticalsPharmaceuticalRegulationSigma Tau

RegeneRx and Lee's Pharma complete license deal for China and Taiwan


USA-based RegeneRx Biopharmaceuticals (OTC Bulletin Board: RGRX) has entered into a licensing agreement…

Asia-PacificLee's PharmaceuticalLicensingOphthalmicsPharmaceuticalRegeneRxResearchSigma Tau

Dyax and Sigma Tau unit pull EU filing on Kalbitor


USA-based Dyax Corp (Nasdaq: DYAX) says it reached agreement with Defiante Farmaceutica, a unit of privately-held…

Defiante FarmaceuticaDyax CorpEuropeKalbitorPharmaceuticalRare diseasesRegulationSigma Tau

Gentium withdraws US NDA for defibrotide


Italian drug developer Gentium SpA (Nasdaq: GENT) saw its shares price plunge 29% to $6.22 on the Nasdaq…

Cardio-vasculardefibrotideGentiumNorth AmericaPharmaceuticalRegulationSigma Tau

Back to top